1. Home
  2. ICU vs NCEL Comparison

ICU vs NCEL Comparison

Compare ICU & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICU
  • NCEL
  • Stock Information
  • Founded
  • ICU 2018
  • NCEL 2008
  • Country
  • ICU United States
  • NCEL Switzerland
  • Employees
  • ICU N/A
  • NCEL N/A
  • Industry
  • ICU Biotechnology: Pharmaceutical Preparations
  • NCEL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICU Health Care
  • NCEL Health Care
  • Exchange
  • ICU Nasdaq
  • NCEL Nasdaq
  • Market Cap
  • ICU 15.9M
  • NCEL 18.3M
  • IPO Year
  • ICU N/A
  • NCEL N/A
  • Fundamental
  • Price
  • ICU $0.31
  • NCEL $3.40
  • Analyst Decision
  • ICU
  • NCEL
  • Analyst Count
  • ICU 0
  • NCEL 0
  • Target Price
  • ICU N/A
  • NCEL N/A
  • AVG Volume (30 Days)
  • ICU 919.2K
  • NCEL 174.0K
  • Earning Date
  • ICU 11-13-2025
  • NCEL 12-01-2025
  • Dividend Yield
  • ICU N/A
  • NCEL N/A
  • EPS Growth
  • ICU N/A
  • NCEL N/A
  • EPS
  • ICU N/A
  • NCEL N/A
  • Revenue
  • ICU $881,000.00
  • NCEL N/A
  • Revenue This Year
  • ICU $820.00
  • NCEL N/A
  • Revenue Next Year
  • ICU $63.37
  • NCEL N/A
  • P/E Ratio
  • ICU N/A
  • NCEL N/A
  • Revenue Growth
  • ICU 1195.59
  • NCEL N/A
  • 52 Week Low
  • ICU $0.29
  • NCEL $3.06
  • 52 Week High
  • ICU $3.07
  • NCEL $7.64
  • Technical
  • Relative Strength Index (RSI)
  • ICU 27.08
  • NCEL N/A
  • Support Level
  • ICU $0.30
  • NCEL N/A
  • Resistance Level
  • ICU $0.52
  • NCEL N/A
  • Average True Range (ATR)
  • ICU 0.05
  • NCEL 0.00
  • MACD
  • ICU -0.01
  • NCEL 0.00
  • Stochastic Oscillator
  • ICU 6.96
  • NCEL 0.00

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: